The Immunogenicity and Safety of 60mcg/30mcg Recombinant Hepatitis B Vaccines in People Who Failed to Respond to Routine Administration of Hepatitis B Vaccines
Clinical trial NCT01203319 · COMPLETED
Trial details
- NCT number
- NCT01203319
- Sponsor
- Jiangsu Province Centers for Disease Control and Prevention
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-11-01
- Primary completion
- 2010-12-01
- Enrollment
- 1091
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.